Chemoinformaics analysis of 3,3,5-Trimethyl-1,5-heptadiene
Molecular Weight | 138.254 | nRot | 3 |
Heavy Atom Molecular Weight | 120.11 | nRig | 2 |
Exact Molecular Weight | 138.141 | nRing | 0 |
Solubility: LogS | -4.534 | nHRing | 0 |
Solubility: LogP | 4.215 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 28.7023 |
nHD | 0 | BPOL | 18.0577 |
QED | 0.523 |
Synth | 3.495 |
Natural Product Likeliness | 1.755 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.029 |
Pgp-sub | 0.001 |
HIA | 0.008 |
CACO-2 | -4.497 |
MDCK | 0.0000252 |
BBB | 0.737 |
PPB | 0.865815 |
VDSS | 1.427 |
FU | 0.147659 |
CYP1A2-inh | 0.48 |
CYP1A2-sub | 0.805 |
CYP2c19-inh | 0.492 |
CYP2c19-sub | 0.879 |
CYP2c9-inh | 0.103 |
CYP2c9-sub | 0.869 |
CYP2d6-inh | 0.439 |
CYP2d6-sub | 0.797 |
CYP3a4-inh | 0.087 |
CYP3a4-sub | 0.275 |
CL | 4.846 |
T12 | 0.304 |
hERG | 0.008 |
Ames | 0.004 |
ROA | 0.009 |
SkinSen | 0.555 |
Carcinogencity | 0.032 |
EI | 0.989 |
Respiratory | 0.086 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.938926 |